Taysha Gene Therapies, Inc. (TSHA) - Stock Prices, Stock Peers & Analysis

Home
TSHA

Company Name	Taysha Gene Therapies, Inc.
Symbol	TSHA
Currency	USD
Price	1.57
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	321,760,510
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.19 - 4.32
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Sean P. Nolan
Website	https://www.tayshagtx.com

An error occurred while fetching data.

About Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment